DISEASE INDICATIONS: HIV/AIDS

MANUFACTURER: Gilead Sciences International Limited

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Biktarvy is a medication approved by the FDA for the treatment of HIV-1. It contains three drugs in a single tablet – tenofovir alafenamide, emtricitabine, and bictegravir – which work together to reduce the viral load of HIV-1 and improve the immune system of those living with the virus.